This study also describes the longitudinal pattern of anti-PAD4 and anti-PAD4/PAD3 antibody titers in patients with early RA, the former of which has only been studied previously in patients with established RA [13]. This evidence concerns the gene PADI3 and rheumatoid arthritis.